Corrigendum: Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening

Siyu Zhang,Changxin Huang,Yongqiang Li,Zhaoyang Li,Ying Zhu,Lili Yang,Haokun Hu,Quan Sun,Mengmeng Liu,Songqiang Cao
DOI: https://doi.org/10.3389/fimmu.2024.1514836
IF: 7.3
2024-12-03
Frontiers in Immunology
Abstract:This article is a correction to: Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening
immunology
What problem does this paper attempt to address?